Table 1.
Potential Risk Factors | Number of Patients | Percentage |
---|---|---|
Race | ||
Caucasian | 503 | 62.3 |
African American | 174 | 21.5 |
Hispanic | 97 | 12.0 |
Asian | 16 | 2.0 |
Other | 18 | 2.2 |
Age | ||
Younger than 40 years | 194 | 24.0 |
40-50 years | 451 | 55.8 |
Older than 50 years | 163 | 20.2 |
Perimenopausal or postmenopausal status | 75 | 9.3 |
History of infertility | 18 | 2.2 |
History of polycystic ovarian syndrome | 13 | 1.6 |
History of diabetes | 26 | 3.2 |
History of hypertension | 158 | 19.6 |
History of cancer | 28 | 3.5 |
History of tamoxifen use | 5 | 0.6 |
History of hormone replacement therapy | 34 | 4.2 |
Oral contraceptive use (ever users) | 248 | 30.7 |
History of smoking | 92 | 11.4 |
Potential Risk Factors | Number of Patients | Percentage |
---|---|---|
Family history of ovarian, breast, endometrial, or colorectal cancer | 94 | 11.8 |
Preoperative Pap test results (within 1 year) | 713 | 88.2 |
Normal | 698 | 97.9 |
Abnormal1 | 15 | 2.1 |
Preoperative or intraoperative endocervical curettage | 30 | 3.7 |
Preoperative ultrasonography | 458 | 56.7 |
Abnormal pap tests included atypical squamous cells of undetermined significance with either negative HPV or colposcopic evaluation (n=13), cervical intraepithelial neoplasia (CIN) 2 on pap test and colposcopy (n=1), and endometrial cells on pap test (n=1).